Critical Therapeutics (CRTX) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks
Critical Therapeutics (CRTX)

An SI Board Since March 2004

Posts	SubjectMarks	Bans	Symbol
31	6	0	CRTX

Emcee: michael_f_murphy	Type: Unmoderated

Introduction Market Data Compact

A biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products designed to regulate the inflammatory response associated with asthma and critical care diseases.

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
31	Knock - Knock CRTX !! Open the door for my 0.317/0.32 entry today please?	Chartgod	-	7/1/2008
30	FDA Approves ZYFLO CR(TM) (Zileuton) Extended-Release Tablets for Critical Thera	nigel bates	-	5/31/2007
29	Critical Therapeutics' Sales Force Gains Access to a Second Product as FDA A	nigel bates	-	5/14/2007
28	Critical Therapeutics and DEY, L.P. Enter into Co-Promotion Agreement for Respir	nigel bates	-	3/14/2007
27	Critical Therapeutics Announces Results of Phase I/II Trial of Intravenous Formu	nigel bates	-	8/23/2006
26	HMGB-1 AS A THERAPEUTIC TARGET FOR INFECTIOUS AND INFLAMMATORY DISORDERS. Revie	nigel bates	-	6/11/2006
25	Nicotine & sepsis - Message 22532915	nigel bates	-	6/11/2006
24	Critical Therapeutics' ZYFLO(R) Receives Distinct Classification under Medic	nigel bates	-	5/25/2006
23	Critical Therapeutics on Target to Submit NDA for Zileuton Controlled-Release Ta	nigel bates	-	5/2/2006
22	Critical Therapeutics Announces Decision to Discontinue Clinical Trial of CTI-01	nigel bates	-	3/15/2006
21	Critical Therapeutics Announces Research on ZYFLO(R) Presented at 2006 AAAAI Ann	nigel bates	-	3/7/2006
20	A 2003 NEJM review of sepsis..I had no idea that to date, the exact cause of dea	zeta1961	-	2/22/2006
19	I was poking around in cyberspace with search word: cytokine and found a couple	zeta1961	-	2/22/2006
18	Critical Therapeutics Announces Abstracts Presented at European Molecular Biolog	nigel bates	-	2/17/2006
17	Critical Therapeutics Completes Dosing of First Patient in Clinical Trial of Int	nigel bates	-	2/15/2006
16	Critical Therapeutics to Initiate Clinical Study of Intravenous Formulation of Z	nigel bates	-	12/20/2005
15	On December 7, 2005, Critical Therapeutics, Inc. (the "Company") enter	nigel bates	-	12/14/2005
14	Critical Therapeutics Achieves Collaboration Milestone in HMGB1 Program Thursday	nigel bates	-	12/8/2005
13	Critical Therapeutics Announces FDA Approval of ZYFLO(R) for the Prevention and	nigel bates	-	9/28/2005
12	Critical Therapeutics to Webcast New York Meeting with Institutional Investors a	nigel bates	-	9/14/2005
11	Read Dr Tracey's book - amazon.com Short, and moving (though could have don	nigel bates	-	9/6/2005
10	Critical Therapeutics Announces Results from Phase II Study of Zileuton in Acne	nigel bates	-	7/14/2005
9	[Zyflo manufacturing deal] >>NEW YORK (AP) -- Shares of Critical Therapeu	tuck	-	6/28/2005
8	>>LEXINGTON, Mass.--(BUSINESS WIRE)--May 23, 2005--Critical Therapeutics,	tuck	-	6/7/2005
7	Critical Therapeutics Announces $54.5 Million Private Placement Tuesday June 7,	nigel bates	-	6/7/2005

Go to reply# or date (mm/dd/yy):